New drop-off rules at BNA spark backlash from rideshare drivers and travelers
NASHVILLE, Tenn. (WKRN) — Starting Tuesday, rideshare users heading to the Nashville International Airport should plan to leave at least 10 minutes earlier.
BNA now requires rideshare drivers to drop off and pick up in the same location — at the Ground Transportation Center.
📧 Have breaking news come to you: →
Abdul Helmandai has driven for Uber Black in Nashville for three years and is a member of the Tennessee Driver Union.
'They are making a decision without discussing it with the drivers,' Helmandai told News 2. 'I mean, the drivers are the backbone; they are the real ones. If there is no driver, then I can bet there would be no airport.'
Helmandai told News 2 that the airport's new policy will slow things down for both drivers and riders. Even before the policy change, Helmandai explained that drivers were already seeing pickup cancellations due to traffic.
'It will take more than an hour to pick up one customer just because drop off and pick up point same place,' Helmandai said.
Airport officials said the move is part of a long-term plan to reduce congestion and support the airport's growth, but Helmandai told News 2 the change would devastate the rideshare business as people move toward more convenient modes of transportation.
'The taxi will become more convenient. You just walk out, 'Taxi!' get in and go,' Helmandai said. 'But if you take a rideshare, definitely it will take 30 minutes, an hour for every driver to get there.'
The change also raises concerns for travelers with mobility issues or young children.
'This place is huge as it is, and to have to make a passenger have to walk that much farther is ridiculous,' Nashville resident Melanie said. '…[For] anyone that has to take a wheelchair on a regular basis, this is going to be totally inconvenient,' she added.
BNA representatives said the walk from the Ground Transportation Center to TSA is under 10 minutes.
'You are just going to add more traffic, more delays, and more problems — and that's one thing Nashville does not need,' Melanie said.
Helmandai's plea to BNA: 'Don't treat us like we are nobody.' To customers: 'I ask you just to keep patience.'
'We deeply value all of our passengers, and ensuring that Nashville International Airport® (BNA®) remains accessible to everyone — is one of our highest priorities. While the walking path from the Ground Transportation Center (GTC) to the Grand Lobby is ADA-compliant and designed to accommodate passengers with mobility needs, as are all our areas at BNA, we understand that every travel experience is unique. Those who require additional support are encouraged to check their rideshare app for alternative drop-off options that may better suit their accessibility needs once the reconfiguration goes into effect on June 3. The comfort and well-being of all our passengers are important to us, and we remain committed to ensuring every passenger feels safe, supported, and welcome at BNA.'
Statement from BNA
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
New Ruling Moves Oregon Closer to Legal In-Home Psilocybin Use
A lawsuit seeking the development of in-home psilocybin services for individuals with disabilities in Oregon will continue after a U.S. district court denied a motion to dismiss on May 30. The case could set an important precedent for future drug laws and accessibility for all Americans, including those with disabilities. In 2020, 56 percent of Oregonians voted in favor of the Oregon Psilocybin Services Act (Measure 109), which directed the Oregon Health Authority to license and regulate psilocybin products and services for individuals aged 21 and older. While a handful of cities in the U.S. had previously decriminalized psilocybin, Oregon was the first state to both decriminalize and create a legal regulatory framework for its supervised use. After two years of rule drafting, the OHA began accepting applications in 2023 for licensed psilocybin service centers, which are regulated facilities where psilocybin can be administered. Rather than focus on selling a product, service centers are geared toward health and wellness and are designed to offer support before, during, and after psilocybin use by licensed service facilitators. This model opened up psilocybin use for most Oregon residents but makes accessing psilocybin services impossible for individuals unable to leave home because of a disability. To fix this oversight in the law, four practitioners licensed by the state to guide people through psilocybin experiences have alleged that the current OHA process fails to reasonably accommodate those with disabilities as required under the Americans with Disabilities Act (ADA). Cusker et al v. OHA was filed after the OHA denied the plaintiffs' request for a process to be developed for in-home psilocybin services to people with disabilities who are unable to visit service centers. In response to the request, state attorneys argued that "there is no legal pathway to make accommodations for psilocybin to be consumed outside of a licensed service center" and that Measure 109 "would need to be amended for accommodations to be permitted." Although the measure only allows the use of psilocybin under facilitator supervision at a service center—which has to comply with specific location requirements, including stipulations prohibiting a center from being located within "the limits of an incorporated city or town" or in areas "zoned exclusively for residential use"—others believe the OHA has the authority and flexibility needed to interpret the language consistent with ADA requirements. But the OHA has declined to address the issue through rule making. The plaintiffs filed the lawsuit in the U.S. District Court for the District of Oregon since the claim revolves around the OHA violating the ADA, a federal law. While psilocybin was decriminalized and legally regulated under Oregon law, it remains classified as a Schedule I controlled substance under the federal Controlled Substances Act. The OHA filed a motion to dismiss the case, arguing that the federal court lacked jurisdiction to decide the case because plaintiffs were asking the court to violate both state and federal law. The federal court would have to order the OHA to break federal law if it required the agency to produce, possess, or administer a Schedule I drug. The OHA also argued that the court would have to order a violation of Oregon's Controlled Substances Act if it required the agency to dispense psilocybin outside of a service center. Ultimately, the court denied the OHA's motion to dismiss, relying on case law involving a non-ADA-compliant marijuana dispensary. In Smith v. 116 S Market LLC (2020), Michael Smith, who is paraplegic, encountered difficulty accessing a dispensary due to a lack of accessible parking spaces, uneven ground between the parking lot and entry, and a noncompliant ramp. The 9th Circuit Court of Appeals ruled in favor of Smith, granting him $4,000 in statutory damages for each encounter, under the rationale that the decision did not force the dispensary owner to distribute a Schedule I drug but merely required ADA compliance—which does not violate federal law. By adopting this reasoning, Cusker will be able to move forward. The post New Ruling Moves Oregon Closer to Legal In-Home Psilocybin Use appeared first on
Yahoo
2 hours ago
- Yahoo
QPS Celebrates 30th Anniversary
NEWARK, Del., June 04, 2025--(BUSINESS WIRE)--QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in 2025. Founded by Dr. Benjamin Chien in 1995 to provide high-quality bioanalytical liquid chromatography with tandem mass spectrometry (LC-MS/MS) contract services, QPS is now recognized as a global leader in contract research. Over the past 30 years, the company has grown from a single office in Delaware, USA to a widely respected, global, full-service CRO with 8 locations spread across the US, EU, Asia, India and Australia, a clinical trial network of over 700 sites and an increased focus on leveraging the power of AI to accelerate clinical trials. Over the years, QPS has grown from a small molecule bioanalysis shop of three people to a global CRO with more than 1,200 employees. "30 years is a major milestone for QPS and I couldn't be more proud of the hard-working and innovative people who choose to work at QPS. They are the backbone of the company, and I am very grateful for their valuable contributions," said founder and CEO of QPS, Dr. Benjamin Chien. "Through QPS, the pharmaceutical and biotechnology industries have access to dedicated, focused scientific expertise across the drug development spectrum. In facilities around the world, QPS has assembled best-in-class instruments, platforms, people and processes required to conduct the studies necessary to support client drug discovery and development programs focused on obesity, type 2 diabetes, oncology, CNS diseases, cell and gene therapy, and more," said Dr. Chien. Since its humble beginnings, QPS has expanded its service options, to include pharmacology, DMPK, toxicology, bioanalysis, translational medicine, leukopaks, PBMCs, cell therapy products, clinical trials, central lab services, and a full range of clinical research services. QPS is known for high-quality data, technical expertise, delivery of promised study timelines, collaborative solutions, and customer-focused strategies. Going forward, QPS plans to continue delivering custom-built research services that accelerate pharmaceutical breakthroughs across the globe. ABOUT QPS HOLDINGS, LLC QPS is a global, full-service, GLP/GCP-compliant contract research organization (CRO) delivering the highest grade of discovery, bioanalysis, preclinical and clinical drug development services. Since 1995, QPS has grown from a small bioanalysis shop into a full-service CRO with 1,200+ employees in the US, Europe, Asia and Australia. Today, QPS offers expanded pharmaceutical contract R&D services with special expertise in pharmacology, DMPK, toxicology, bioanalysis, translational medicine, leukopaks, PBMCs and cell therapy products, clinical trials, and clinical research services. An award-winning leader focused on bioanalysis and clinical trials, QPS is known for proven quality standards, technical expertise, a flexible approach to research, client satisfaction, and turnkey laboratories and facilities. Through continual enhancements in capacities and resources, QPS stands tall in its commitment to delivering superior quality, skilled performance and trusted service to its valued customers. For more information, visit or email info@ View source version on Contacts QPS CONTACT: Name: Gabrielle PastorePhone: 1-302-635-4290Email: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
New York Post
2 hours ago
- New York Post
Save 20% on this Waterpik Cordless Advanced 2.0 Water Flosser today on Amazon
New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. 'You only get one chance at a first impression,' the old saying goes. And like many old sayings ('A rolling stone gathers no moss,' 'You can lead a horse to water, but you can't make it drink,' etc.), it just so happens to be entirely true. In our opinion, putting your best teeth forward is essential; flashing such a brilliant smile that you're practically guaranteed a good first impression. One easy way to get there? Flossing with the Waterpik Cordless Advanced 2.0 Water Flosser, available for 20% off this week on Amazon. Advertisement Featuring PrecisionPulse technology to deliver a combination of water pressure and pulsations, this top-selling Waterpik Flosser product caters to gentle, sensitive cleaning or deep, powerful cleansing for a personalized experience, promoting gum health, fresh breath, and, of course, good first impressions. Amazon The Waterpik Cordless Advanced 2.0 Water Flosser (WP-580) offers a compact, portable solution for effective oral care. It features a 360° rotating tip handle, three pressure settings, and a 7-ounce removable reservoir for up to 45 seconds of flossing time. With rapid magnetic charging, waterproof design, and ADA acceptance, it's ideal for travel and small spaces. Best of all? It's available for 20% off for a limited time this week on Amazon. This article was written by P.J. McCormick, New York Post Commerce Deals Writer/Reporter. P.J. is an expert deal-finder, sifting through endless brands and retailers to deliver only the best savings opportunities on truly worthwhile products. P.J. finds Prime Day-worthy deals all year long on some of our favorite products we've tested and our readers' beloved best-sellers, from Wayfair furniture sales to the lowest prices on Apple AirPods. P.J. has been scouring sales for Post Wanted shoppers since 2022 and previously held positions at Rolling Stone, Pitchfork and Hyperallergic. Please note that deals can expire, and all prices are subject to change. Hunting for a headline-worthy haul? Keep shopping with Post Wanted.
